Detalhe da pesquisa
1.
Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3.
J Natl Compr Canc Netw
; 21(11): 1110-1116, 2023 08 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37643636
2.
Agranulocytosis secondary to zinc excess: Clinically relevant observations, including response to G-CSF and oral copper.
Clin Case Rep
; 8(12): 2895-2898, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33363846